Factors Associated with Early Discontinuation of Foslevodopa/Foscarbidopa in Parkinson's Disease.
Factors Associated with Early Discontinuation of Foslevodopa/Foscarbidopa in Parkinson's Disease.
Where did the research take place?
The study site has not been established. Author addresses may differ from where the research occurred.
Osaka, JP · Author affiliation
Department of Neurology, The University of Osaka Graduate School of Medicine, Suita, Japan.Location evidence
Suita, JP · Author affiliation
Department of Neurology, The University of Osaka Graduate School of Medicine, Suita, Japan.Location evidence
Toyonaka, JP · Author affiliation
Department of Neurology, National Hospital Organization Osaka Toneyama Medical Center, Toyonaka, Japan.Location evidence
A plain-language reading has not been prepared for this paper yet.